John McEwen
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 5
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Pharmaceutical studies and practices 8
- Pharmacological Effects and Toxicity Studies 5
- Co-authors
- A. Riis (1 shared paper)Anna Lindholm Olinder (1 shared paper)D S Hewick (1 shared paper)David Henry (2 shared papers)Andrew Dawson (1 shared paper)Keith Yates (2 shared papers)T. A. Moreland (5 shared papers)Christian de Mey (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (11 papers)The Medical Journal of Australia (8 papers)Drug Safety (6 papers)Biopharmaceutics & Drug Disposition (2 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
John McEwen
69 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 225
- Toxicology 83
- Endocrinology, Diabetes and Metabolism 218
- Urology 72
- Pharmaceutical Science 76
Countries citing papers authored by John McEwen
This map shows the geographic impact of John McEwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McEwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McEwen more than expected).
Fields of papers citing papers by John McEwen
This network shows the impact of papers produced by John McEwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McEwen. The network helps show where John McEwen may publish in the future.
Co-authors
The 25 scholars most cited alongside John McEwen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 160 | |
| 2 | 1973 | 100 | |
| 3 | 1989 | 93 | |
| 4 | 1998 | 79 | |
| 5 | 1980 | 74 | |
| 6 | 1968 | 46 | |
| 7 | 2014 | 39 | |
| 8 | 2002 | 39 | |
| 9 | 2000 | 36 | |
| 10 | 1995 | 36 | |
| 11 | 1987 | 34 | |
| 12 | 1989 | 33 | |
| 13 | Clopidogrel bioavailability: absence of influence of food or antacids. | 1999 | 30 |
| 14 | 1984 | 29 | |
| 15 | 1991 | 26 | |
| 16 | 1996 | 25 | |
| 17 | 1989 | 24 | |
| 18 | 1990 | 24 | |
| 19 | 1984 | 22 | |
| 20 | 2018 | 22 |
About John McEwen
John McEwen is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Toxicology, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism, having authored 72 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Pharmaceutical studies and practices (8 papers), Pharmaceutical Practices and Patient Outcomes (8 papers), Analytical Methods in Pharmaceuticals (6 papers), Pharmaceutical Economics and Policy (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pharmacology (225 citations), Toxicology (83 citations), Endocrinology, Diabetes and Metabolism (218 citations), Urology (72 citations) and Pharmaceutical Science (76 citations). John McEwen has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include A. Riis, Anna Lindholm Olinder, D S Hewick, David Henry, Andrew Dawson, Keith Yates, T. A. Moreland, Christian de Mey, Martin C. Michel and D. T. Greenwood. Their work appears in journals such as British Journal of Clinical Pharmacology, The Medical Journal of Australia, Drug Safety, Biopharmaceutics & Drug Disposition and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.